Atopic Dermatitis

>

On the HCPLive Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Latest News

Positive Long-Term Data Shown in Patients with Atopic Dermatitis Treated with Rademikibart
Positive Long-Term Data Shown in Patients with Atopic Dermatitis Treated with Rademikibart

November 22nd 2023

These pivotal trial results from a study in China indicated the potential of this drug as a quarterly treatment for individuals with eczema.

Dupilumab for Eczema: Spotlighting 4-Year Survival Rate Data
Dupilumab for Eczema: Spotlighting 4-Year Survival Rate Data

November 19th 2023

Atopic Dermatitis: Spotlighting the Unseen Effects on Adolescents
Atopic Dermatitis: Spotlighting the Unseen Effects on Adolescents

October 30th 2023

JAK Inhibitors Versus Monoclonal Antibodies: Which to Choose?
JAK Inhibitors Versus Monoclonal Antibodies: Which to Choose?

October 21st 2023

Latest Phase 3 Trial Data Announced for Upadacitinib Treatment of Atopic Dermatitis
Latest Phase 3 Trial Data Announced for Upadacitinib Treatment of Atopic Dermatitis

October 14th 2023

Video Series
Video Interviews
Podcasts
Advances in Pediatric Eczema Highlight 2022

More News

© 2023 MJH Life Sciences

All rights reserved.